Amplify Weight Loss Drug & Treatment ETF (THNR)
$24.40-0.45%Close
Snapshot
- 1 week
- -0.1%+1.4% vs SPY
- 1 month
- -3.7%-4.3% vs SPY
- Assets
- $5.6M
- Expense ratio
- 0.59%
- Fund type
- EQUITY
- Distribution yield
- 1.70%
Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year · Fund: Income score, Valuation
Price & returns: 3 years, 5 years
Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Fund
About
Amplify Weight Loss Drug & Treatment ETF (THNR). The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
